# Efficacy of Bilastine Up-dosing (40 mg ) Versus Combination of Bilastine (20 mg )With Levocitirizine (5 mg) in the Treatment of Chronic Spontaneous Urticaria

> **NCT07365683** · NA · COMPLETED · sponsor: **Derma Techno Pakistan** · enrollment: 60 (actual)

## Conditions studied

- Chronic Spontaneous Urticaria (CSU)

## Interventions

- **DRUG:** tab bilastine 20 mg
- **DRUG:** tab bilastine 20 mg + tab levocetrizine 5 mg

## Key facts

- **NCT ID:** NCT07365683
- **Lead sponsor:** Derma Techno Pakistan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-18
- **Primary completion:** 2026-01-10
- **Final completion:** 2026-01-17
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07365683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07365683, "Efficacy of Bilastine Up-dosing (40 mg ) Versus Combination of Bilastine (20 mg )With Levocitirizine (5 mg) in the Treatment of Chronic Spontaneous Urticaria". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07365683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*